Bisphenol A-Induced Endocrine Dysfunction and its Associated Metabolic Disorders

Area of Science:

• Endocrinology and Toxicology
• Molecular Biology
• Metabolic Health

Background:

• Bisphenol A (BPA) is a ubiquitous endocrine-disrupting chemical (EDC) found in consumer products.
• Exposure to BPA is linked to endocrine dysfunctions and metabolic disorders including obesity, insulin resistance, and polycystic ovarian syndrome.
• BPA's classification as a chemical of very serious concern by the European Chemical Agency highlights its significant health threat.

Approach:

• This review synthesizes current research on the cellular and molecular mechanisms of BPA's endocrine-disrupting effects.
• It examines BPA's interaction with estrogen receptors and G-protein coupled receptors.
• The review investigates BPA's role as an obesogen and its impact on cellular homeostasis and mitochondrial function.

Key Points:

• BPA mimics estrogen and interferes with thyroid hormone pathways, disrupting endocrine signaling.
• It promotes adipogenesis, leading to increased lipid accumulation and obesity.
• BPA exacerbates oxidative stress and mitochondrial dysfunction, contributing to metabolic syndrome.

Conclusions:

• BPA exposure triggers a cascade of endocrine dysfunctions with profound metabolic consequences.
• Understanding these mechanisms is crucial for mitigating BPA's adverse health effects.
• Further research is needed to fully elucidate BPA's impact on reproductive and non-reproductive health.